Zanetti A, Ferroni P, Bergamini F, Legnani F
Ric Clin Lab. 1979 Jan-Mar;9(1):35-9. doi: 10.1007/BF02905025.
HBeAg/anti-HBe and Dane particle-associated DNA polymerase activity were detected in serum samples from 358 HBsAg asymptomatic carriers found during normal routine screening of 11,200 blood donors (HBsAg prevalence 3.1%). Since virus specific DNA polymerase activity and HBeAg seem to be associated in some way with hepatitis B virus infectivity and liver damage, 5% of the HBsAg carriers examined, as detected by the presence of HBeAg, and 9.5%, as shown by DNA polymerase activity, can be expected to have liver damage and a potential risk of transmitting hepatitis B to contacts. On the other hand, 48% of subjects were theoretically healthy and non-infective because of the presence of anti-HBe in their blood. The differentiation of groups of asymptomatic HBsAg carriers, on the basis of these serological markers, may have important clinical and epidemiological implications.
在对11200名献血者进行常规筛查时发现的358例HBsAg无症状携带者的血清样本中,检测到了HBeAg/抗-HBe以及与 Dane颗粒相关的DNA聚合酶活性(HBsAg流行率为3.1%)。由于病毒特异性DNA聚合酶活性和HBeAg似乎在某种程度上与乙型肝炎病毒感染性及肝损伤相关,预计通过检测HBeAg存在情况,所检查的HBsAg携带者中有5%存在肝损伤并有将乙型肝炎传播给接触者的潜在风险;而通过DNA聚合酶活性检测显示,这一比例为9.5%。另一方面,理论上48%的受试者血液中存在抗-HBe,因而健康且无传染性。基于这些血清学标志物对无症状HBsAg携带者群体进行区分,可能具有重要的临床和流行病学意义。